Is telehealth allowed to prescribe Lithium in Pennsylvania?

Introduction

Managing bipolar disorder often requires consistent medication management, but access to psychiatric care can be challenging due to provider shortages, geographic barriers, and scheduling constraints. Telehealth has emerged as a convenient solution for many patients seeking mental health treatment, but questions about the legality of prescribing bipolar medications online remain common. This comprehensive guide clarifies the current legal landscape for telehealth prescribing of common bipolar medications like Lithium, Lamotrigine (Lamictal), and Quetiapine (Seroquel) in 2026, providing patients and providers with clear information about what’s legally possible in virtual care settings.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Regulations: Good News for Bipolar Medication Access

Non-Controlled Medications Have Fewer Restrictions

Unlike treatments for conditions like ADHD that often involve controlled substances, the primary medications for bipolar disorder are not classified as controlled substances under federal law. This key distinction means these medications face significantly fewer telehealth prescribing restrictions:

• Lithium (various brands): Unscheduled medication
• Lamotrigine (Lamictal): Unscheduled medication
• Quetiapine (Seroquel): Unscheduled medication

Because these medications aren’t controlled substances, they aren’t subject to the DEA’s special telemedicine rules that govern medications with abuse potential. This means federal law permits prescribing these medications via telehealth without requiring an initial in-person examination.

DEA Telemedicine Rules: What You Need to Know

The Ryan Haight Online Pharmacy Consumer Protection Act—which requires in-person exams before prescribing controlled substances—doesn’t apply to bipolar medications like Lithium, Lamotrigine, and Quetiapine. While the DEA’s temporary flexibilities for controlled substances (currently extended through December 31, 2026) have been major news in telehealth, they don’t directly impact these non-controlled bipolar treatments.

This regulatory distinction is good news for patients seeking bipolar treatment via telehealth: federal law fully permits telehealth providers to prescribe these medications after an appropriate remote evaluation, making care more accessible.

State-by-State Telehealth Rules: What’s Allowed Where?

While federal law permits telehealth prescribing of bipolar medications, state laws also play an important role in determining what’s allowed. Here’s what you should know about several key states:

California

California fully permits telehealth prescribing of non-controlled bipolar medications. State law explicitly allows ‘appropriate prior examination’ to be conducted via telehealth, with no in-person requirement for these medications. Nurse Practitioners in California are currently transitioning to independent practice authority under AB 890, which will be fully effective by 2026.

Texas

Texas mental health telehealth prescribing is explicitly allowed for non-controlled medications. While Texas has restrictions on some controlled substances, there is no in-person requirement for medications like Lithium, Lamotrigine, or Quetiapine. NPs in Texas require physician supervision via a Prescriptive Authority Agreement.

New York

New York permits telehealth prescribing of non-controlled bipolar medications without an in-person visit. In 2025, New York implemented new rules for controlled substances requiring in-person exams (with exceptions), but these do not affect bipolar medications. New York NPs can practice independently after 3,600 hours of experience.

Florida

Florida allows telehealth prescribing of non-controlled medications without an in-person requirement. While Florida restricts telehealth prescribing of some Schedule II controlled substances, these restrictions don’t apply to bipolar medications. NPs in Florida must practice under a physician protocol.

New Hampshire

New Hampshire permits telehealth prescribing of non-controlled medications but requires at least an annual exam (which can be done via telehealth) for ongoing prescriptions. NPs in New Hampshire have full practice authority.

The good news: No state outright prohibits telehealth prescribing of non-controlled bipolar medications. Even states with stricter telehealth laws generally allow these prescriptions as long as the virtual visit meets the standard of care.

Who Can Prescribe Bipolar Medications via Telehealth?

Provider qualifications and scope of practice are important considerations when seeking telehealth treatment for bipolar disorder:

Physician vs. Nurse Practitioner Authority

• Physicians (MD/DO) can prescribe these medications via telehealth in all 50 states
• Nurse Practitioners (NPs) can prescribe these medications in all states, though their level of required supervision varies:
• Independent Practice States: Over 30 states allow NPs full independent practice authority, including prescribing non-controlled medications without physician oversight
• Collaborative Practice States: States like Texas, Florida, Pennsylvania, and Georgia require NPs to have a collaborative agreement with a physician, but this doesn’t prevent telehealth prescribing
• Restricted Practice States: Even in the most restrictive states, NPs can still prescribe non-controlled medications with proper physician collaboration

At Klarity Health, patients are matched with appropriately credentialed providers licensed in their state who can legally prescribe these medications. All prescribers must be properly licensed in the state where the patient is physically located at the time of the telehealth visit.

The Telehealth Prescription Process for Bipolar Medications

What to Expect During Your Virtual Visit

A legitimate telehealth evaluation for bipolar disorder should include:

1. Comprehensive assessment: A thorough psychiatric evaluation following DSM-5 criteria for bipolar disorder
2. Medical history review: Including past treatments, other medical conditions, and current medications
3. Mental status examination: Conducted virtually to assess your current symptoms
4. Treatment planning: Discussion of medication options, potential side effects, and follow-up schedule
5. Laboratory recommendations: For medications like Lithium, the provider will typically order baseline blood tests
6. Emergency planning: Establishing protocols in case of urgent situations

How Prescriptions Are Handled

If medication is appropriate, your provider will:

1. Send an electronic prescription directly to your pharmacy
2. Specify the initial supply (often 30 days for new patients)
3. Schedule follow-up appointments to monitor effectiveness and side effects
4. Order any necessary lab work (especially important for Lithium)
5. Consider adding refills after stability is established

Klarity Health makes this process seamless by facilitating electronic prescribing and follow-up scheduling, ensuring patients receive continuous care while meeting all legal requirements.

Special Considerations for Specific Bipolar Medications

Lithium

• Legal status: Not controlled, can be prescribed via telehealth in all states
• Clinical requirements: Requires regular blood level monitoring; telehealth providers will typically order baseline labs and periodic follow-up tests
• Supply limits: No federal quantity limits, though providers often start with 30-day supplies
• Follow-up expectations: More frequent monitoring typically required due to narrow therapeutic window

Lamotrigine (Lamictal)

• Legal status: Not controlled, can be prescribed via telehealth in all states
• Clinical requirements: Requires gradual dose titration to minimize risk of serious rash
• Supply limits: No legal limits, but initial prescriptions often limited to support careful titration
• Follow-up expectations: Regular check-ins during dose adjustment phase

Quetiapine (Seroquel)

• Legal status: Not controlled, can be prescribed via telehealth in all states
• Clinical considerations: Some providers monitor more closely due to metabolic side effects
• Supply limits: No legal quantity limits, though clinical judgment applies
• Special monitoring: Some states track it in their Prescription Monitoring Programs despite not being controlled

Patient Eligibility for Telehealth Bipolar Treatment

Good Candidates for Telehealth

Telehealth is generally appropriate for:

• Adults with bipolar I or II disorder in relatively stable condition
• Patients able to participate in video appointments
• Those with reliable internet access and a private space for sessions
• Individuals able to attend periodic lab testing when needed
• Patients without severe symptoms requiring immediate in-person intervention

When In-Person Care May Be Recommended

Your telehealth provider might recommend in-person evaluation if you have:

• Severe mania or psychosis
• Active suicidal ideation or self-harm risk
• Complex medical conditions requiring physical examination
• Significant medication side effects that need to be assessed in person
• Difficulty participating effectively in telehealth visits

Klarity Health providers are trained to recognize when telehealth is appropriate and when patients might benefit from in-person care, ensuring patient safety while maximizing convenience.

Common Misconceptions About Telehealth for Bipolar Disorder

Myth: Online Psychiatrists Can’t Prescribe ‘Real’ Medications

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,this%20flexibility%20has%20been%20prolonged
• https://www.sheppardhealthlaw.com/2017/07/articles/health-information-technology/online-pharmacies/#:~:text=,Internet%20without%20a%20valid%20prescription
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=In%20late%202024%2C%20the%20U,V
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=person%20evaluation%20requirement%20under%20the,provide%20short%20term%20stability%20while
• https://www.ama-assn.org/health-care-advocacy/advocacy-update/jan-24-2025-national-advocacy-update#:~:text=telemedicine%20registrations%20for%20prescribing%20Schedule,Like%20the%20buprenorphine%20rule
• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=The%20Fourth%20Temporary%20Extension%2C%20along,flexibilities%20under%20the%20fourth%20temporary
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=1,long%20as%20the%20issuing%20provider
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=1,a
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=5,a%20physician%20must%20generally%20use